Suchergebnisse - "FURBERG, C"

PubPharm (351)

1

Efficacy and safety of LDL-lowering therapy among men and women : meta-analysis of individual data from 174,000 participants in 27 randomised trials

enthalten in: Lancet (London, England) | 2015

von Cholesterol Treatment Trialists' (CTT) Collaboration | Fulcher, J. | O'Connell, R. | +117

CommentIn: Lancet. 2015 Apr 11;385(9976):1368-9. - PMID 25595662

2

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease : meta-analysis of individual data from 27 randomised trials

enthalten in: Lancet (London, England) | 2012

von Cholesterol Treatment Trialists' (CTT) Collaborators | Mihaylova, B. | Emberson, J. | +108

CommentIn: Lancet. 2012 Aug 11;380(9841):545-7. - PMID 22607823

3

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes : results from the Cardiovascular Health Study

enthalten in: The Journal of clinical endocrinology and metabolism | 2012

von Nelson, T. | Biggs, M. | Kizer, J. | +4

4

Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) and Future Risk of Type 2 Diabetes: Results from the Cardiovascular Health Study

enthalten in: The journal of clinical endocrinology & metabolism | 2012

von Nelson, T. | Biggs, M. | Kizer, J. | +4

5

Lack of effect of lowering LDL cholesterol on cancer : meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

enthalten in: PloS one | 2012

von Cholesterol Treatment Trialists' (CTT) Collaboration | Emberson, J. | Kearney, P. | +110

6

Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes : the Cardiovascular Health Study

enthalten in: Diabetologia | 2011

von Nelson, T. | Kamineni, A. | Psaty, B. | +5

7

Lipoprotein-associated phospholipase $ A_{2} $ and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

enthalten in: Diabetologia | 2010

von Nelson, T. | Kamineni, A. | Psaty, B. | +5

8

Lipoprotein-associated phospholipase $ A_{2} $ and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

enthalten in: Diabetologia | 2010

von Nelson, T. | Kamineni, A. | Psaty, B. | +5

9

Lipoprotein-associated phospholipase $ A_{2} $ and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

enthalten in: Diabetologia | 2010

von Nelson, T. | Kamineni, A. | Psaty, B. | +5

10

Efficacy and safety of more intensive lowering of LDL cholesterol : a meta-analysis of data from 170,000 participants in 26 randomised trials

enthalten in: Lancet (London, England) | 2010

von Cholesterol Treatment Trialists’ (CTT) Collaboration | Baigent, C. | Blackwell, L. | +109

CommentIn: Lancet. 2010 Nov 13;376(9753):1622-4. - PMID 21067806

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]